Autism as early neurodevelopmental disorder: Evidence for an sAPPamediated anabolic pathway

Debomoy K. Lahiri, Deborah K. Sokol, Craig Erickson, Balmiki Ray, Chang Y. Ho, Bryan Maloney

Research output: Contribution to journalReview article

37 Citations (Scopus)

Abstract

Autism is a neurodevelopmental disorder marked by social skills and communication deficits and interfering repetitive behavior. Intellectual disability often accompanies autism. In addition to behavioral deficits, autism is characterized by neuropathology and brain overgrowth. Increased intracranial volume often accompanies this brain growth. We have found that the Alzheimer's disease (AD) associated amyloid-ß precursor protein (APP), especially its neuroprotective processing product, secreted APP a (sAPPa), is elevated in persons with autism. This has led to the "anabolic hypothesis" of autism etiology, in which neuronal overgrowth in the brain results in interneuronal misconnections that may underlie multiple autism symptoms. We review the contribution of research in brain volume and of APP to the anabolic hypothesis, and relate APP to other proteins and pathways that have already been directly associated with autism, such as fragile X mental retardation protein (FMRP), Ras small GTPase/Extracellular Signal-Regulated Kinase (Ras/ERK), and phosphoinositide 3 kinase/protein kinase B/mammalian target of rapamycin (PI3K/Akt/mTOR). We also present additional evidence of MRI intracranial measurements in favor of the anabolic hypothesis. Finally, since it appears that APP's involvement in autism is part of a multi-partner network, we extend this concept into the inherently interactive realm of epigenetics. We speculate that the underlying molecular abnormalities that influence APP's contribution to autism are epigenetic markers overlaid onto potentially vulnerable gene sequences due to environmental influence.

Original languageEnglish (US)
JournalFrontiers in Cellular Neuroscience
Issue numberMAY
DOIs
StatePublished - May 27 2013

Fingerprint

Autistic Disorder
Amyloid beta-Protein Precursor
Brain
Epigenomics
Mitogen-Activated Protein Kinase 6
Fragile X Mental Retardation Protein
Neurodevelopmental Disorders
ras Proteins
Proto-Oncogene Proteins c-akt
1-Phosphatidylinositol 4-Kinase
Monomeric GTP-Binding Proteins
Sirolimus
Phosphatidylinositol 3-Kinases
Intellectual Disability
Alzheimer Disease
Communication
Growth
Research

Keywords

  • Alzheimer's-autism continuum
  • Anabolic hypothesis
  • Cranial volume
  • Neurite overgrowth

ASJC Scopus subject areas

  • Cellular and Molecular Neuroscience

Cite this

Autism as early neurodevelopmental disorder : Evidence for an sAPPamediated anabolic pathway. / Lahiri, Debomoy K.; Sokol, Deborah K.; Erickson, Craig; Ray, Balmiki; Ho, Chang Y.; Maloney, Bryan.

In: Frontiers in Cellular Neuroscience, No. MAY, 27.05.2013.

Research output: Contribution to journalReview article

@article{eb9e2e55761b4002ab4ee997f258154e,
title = "Autism as early neurodevelopmental disorder: Evidence for an sAPPamediated anabolic pathway",
abstract = "Autism is a neurodevelopmental disorder marked by social skills and communication deficits and interfering repetitive behavior. Intellectual disability often accompanies autism. In addition to behavioral deficits, autism is characterized by neuropathology and brain overgrowth. Increased intracranial volume often accompanies this brain growth. We have found that the Alzheimer's disease (AD) associated amyloid-{\ss} precursor protein (APP), especially its neuroprotective processing product, secreted APP a (sAPPa), is elevated in persons with autism. This has led to the {"}anabolic hypothesis{"} of autism etiology, in which neuronal overgrowth in the brain results in interneuronal misconnections that may underlie multiple autism symptoms. We review the contribution of research in brain volume and of APP to the anabolic hypothesis, and relate APP to other proteins and pathways that have already been directly associated with autism, such as fragile X mental retardation protein (FMRP), Ras small GTPase/Extracellular Signal-Regulated Kinase (Ras/ERK), and phosphoinositide 3 kinase/protein kinase B/mammalian target of rapamycin (PI3K/Akt/mTOR). We also present additional evidence of MRI intracranial measurements in favor of the anabolic hypothesis. Finally, since it appears that APP's involvement in autism is part of a multi-partner network, we extend this concept into the inherently interactive realm of epigenetics. We speculate that the underlying molecular abnormalities that influence APP's contribution to autism are epigenetic markers overlaid onto potentially vulnerable gene sequences due to environmental influence.",
keywords = "Alzheimer's-autism continuum, Anabolic hypothesis, Cranial volume, Neurite overgrowth",
author = "Lahiri, {Debomoy K.} and Sokol, {Deborah K.} and Craig Erickson and Balmiki Ray and Ho, {Chang Y.} and Bryan Maloney",
year = "2013",
month = "5",
day = "27",
doi = "10.3389/fncel.2013.00094",
language = "English (US)",
journal = "Frontiers in Cellular Neuroscience",
issn = "1662-5102",
publisher = "Frontiers Research Foundation",
number = "MAY",

}

TY - JOUR

T1 - Autism as early neurodevelopmental disorder

T2 - Evidence for an sAPPamediated anabolic pathway

AU - Lahiri, Debomoy K.

AU - Sokol, Deborah K.

AU - Erickson, Craig

AU - Ray, Balmiki

AU - Ho, Chang Y.

AU - Maloney, Bryan

PY - 2013/5/27

Y1 - 2013/5/27

N2 - Autism is a neurodevelopmental disorder marked by social skills and communication deficits and interfering repetitive behavior. Intellectual disability often accompanies autism. In addition to behavioral deficits, autism is characterized by neuropathology and brain overgrowth. Increased intracranial volume often accompanies this brain growth. We have found that the Alzheimer's disease (AD) associated amyloid-ß precursor protein (APP), especially its neuroprotective processing product, secreted APP a (sAPPa), is elevated in persons with autism. This has led to the "anabolic hypothesis" of autism etiology, in which neuronal overgrowth in the brain results in interneuronal misconnections that may underlie multiple autism symptoms. We review the contribution of research in brain volume and of APP to the anabolic hypothesis, and relate APP to other proteins and pathways that have already been directly associated with autism, such as fragile X mental retardation protein (FMRP), Ras small GTPase/Extracellular Signal-Regulated Kinase (Ras/ERK), and phosphoinositide 3 kinase/protein kinase B/mammalian target of rapamycin (PI3K/Akt/mTOR). We also present additional evidence of MRI intracranial measurements in favor of the anabolic hypothesis. Finally, since it appears that APP's involvement in autism is part of a multi-partner network, we extend this concept into the inherently interactive realm of epigenetics. We speculate that the underlying molecular abnormalities that influence APP's contribution to autism are epigenetic markers overlaid onto potentially vulnerable gene sequences due to environmental influence.

AB - Autism is a neurodevelopmental disorder marked by social skills and communication deficits and interfering repetitive behavior. Intellectual disability often accompanies autism. In addition to behavioral deficits, autism is characterized by neuropathology and brain overgrowth. Increased intracranial volume often accompanies this brain growth. We have found that the Alzheimer's disease (AD) associated amyloid-ß precursor protein (APP), especially its neuroprotective processing product, secreted APP a (sAPPa), is elevated in persons with autism. This has led to the "anabolic hypothesis" of autism etiology, in which neuronal overgrowth in the brain results in interneuronal misconnections that may underlie multiple autism symptoms. We review the contribution of research in brain volume and of APP to the anabolic hypothesis, and relate APP to other proteins and pathways that have already been directly associated with autism, such as fragile X mental retardation protein (FMRP), Ras small GTPase/Extracellular Signal-Regulated Kinase (Ras/ERK), and phosphoinositide 3 kinase/protein kinase B/mammalian target of rapamycin (PI3K/Akt/mTOR). We also present additional evidence of MRI intracranial measurements in favor of the anabolic hypothesis. Finally, since it appears that APP's involvement in autism is part of a multi-partner network, we extend this concept into the inherently interactive realm of epigenetics. We speculate that the underlying molecular abnormalities that influence APP's contribution to autism are epigenetic markers overlaid onto potentially vulnerable gene sequences due to environmental influence.

KW - Alzheimer's-autism continuum

KW - Anabolic hypothesis

KW - Cranial volume

KW - Neurite overgrowth

UR - http://www.scopus.com/inward/record.url?scp=84878445323&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84878445323&partnerID=8YFLogxK

U2 - 10.3389/fncel.2013.00094

DO - 10.3389/fncel.2013.00094

M3 - Review article

C2 - 23801940

AN - SCOPUS:84878445323

JO - Frontiers in Cellular Neuroscience

JF - Frontiers in Cellular Neuroscience

SN - 1662-5102

IS - MAY

ER -